Find your path to Wei-Li
21 people in our graph share verified history with Wei-Li — schools, employers, funds. One of them is your warm intro.
Tomer BerkovitzunlockedWei-Li: together at Omada Health (2021–2025)
×8Wei-Li: together at Omada Health
Wei-Li: together at Pharmacia & Upjohn
Wei-Li: together at AmCham Taiwan
About
Wei-Li Shao serves as Chief Revenue Officer at Abnormal AI and works as a go-to-market advisor. He has led global sales teams across multiple stages of company growth, including pre-revenue, IPO, and post-IPO phases.
President at Omada Health
Intro paths
→
In turn, Wei-Li can intro founders to Omada Health's investors below.
Omada Health's investors · 21
Andreessen HorowitzMenlo Park · $500K – $50M checks · since 2015Balaji Srinivasan$10K – $500K checksBlackbird GiantsSydney · since 2015Canvas VenturesCampbell · $5M – $20M checks · since 2015Civilization Ventures Management, LlcTiburon · $1M – $10M checks · since 2015Designer FundSan Francisco · $100K – $1M checks · since 2015Founder CollectiveCambridge · since 2015Healthtech CapitalSilicon Valley · since 2015J-VenturesSilicon Valley · $250K – $1M checks · since 2015Kaiser Permanente VenturesSan Francisco · $2M – $5M checks · since 2015Kapor CapitalOakland · $100K – $1M checks · since 2015Khosla VenturesMenlo Park · $5K – $50M checks · since 2015National Institutes of Health (NIH)since 2015New Enterprise Associates (NEA)Menlo Park · $200K – $40M checksNorwest Venture PartnersMenlo Park · $10M – $30M checks · since 2015Revelation PartnersSausalito · $5M – $50M checksSanofi VenturesCambridge · $5M checks · since 2015The Vertical GroupBerkeley Heights · $250K – $5M checks · since 2015Trousdale VenturesWest Hollywood · $1M – $5M checks · since 2015US Venture PartnersMenlo Park · $500K – $10M checks · since 2015Wonder VenturesLos Angeles · $100K – $1.5M checks · since 2015
Co-founders at Omada Health
AD
Andrew DiMichelleExecutive Officer, Director
AJ
Adrian JamesExecutive Officer, Director
SD

Sean DuffyExecutive Officer, Director
Experience
- Omada HealthPresidentcurrent2021 — presentSan Francisco, California, United States
- Omada HealthChief Commercial Officer2019 — 2021San Francisco Bay Area
- Eli Lilly and CompanyVice President, Neurosciences Business Unit2017 — 2019Greater Indianapolis
- Eli Lilly and CompanyVice President, Sales and Operations, Lilly USA LLC2015 — 2017Indianapolis, Indiana
- Eli Lilly and CompanyVice President, Diabetes Business Unit, China2013 — 2015Shanghai, China
- Eli Lilly and CompanyBusiness Unit Leader, Alzheimer's Business Unit, USA2011 — 2013Indianapolis, Indiana
- Eli Lilly and CompanyGeneral Manager, Taiwan2009 — 2011Taipei–Keelung Metropolitan area
- International Research-Based Pharmaceutical Manufacturers Association, IRPMADirector Board Of Directors2009 — 2011
- AmCham TaiwanBoard of Govenors2010Taipei City, Taiwan
- AmCham TaiwanCo-Chairman Pharmaceutical Committee2009 — 2010Taipei City, Taiwan
- PhRMAChairman2009 — 2010Taipei City, Taiwan
- Medicines New ZealandDirector Board Of Directors2007 — 2008
- AmCham New ZealandDirector Board Of Directors2007 — 2008Auckland, New Zealand
- Eli Lilly and CompanyGeneral Manager, New Zealand2006 — 2008Auckland Metropolitan Area
- Eli Lilly and CompanyBrand Director, US Diabetes Strategy2006Indianapolis, Indiana
- Eli Lilly and CompanyBrand Director, Managed Care / Healthcare Professional Marketing, Men's Health2005 — 2006Indianapolis, Indiana
- Eli Lilly and CompanyBrand Manager, Healthcare Professional and Strategy, Women's Health2001 — 2005Indianapolis, Indiana
- Pharmacia Corporation (Pfizer)District Sales Manager, Primary Care, Urology, Oncology1997 — 1999Chicago, Illinois
- Pharmacia & UpjohnSales Representative1993 — 1996Dallas, Texas
Skills & more
P&L Responsibility21Pharmaceutical Industry87Cross-functional Team Leadership99Product Launch44Pharmaceutical Sales54Public Policy13Oncology43Diabetes13Dermatology1Competitive Analysis2Clinical Development1Competitive Intelligence1
+3 more
CardiologyCommercializationBiotechnologyLanguages English · Mandarin
From Wei-Li's professional profile.
Frequently asked questions
- Who is Wei-Li Shao?
- Wei-Li Shao serves as Chief Revenue Officer at Abnormal AI and works as a go-to-market advisor. He has led global sales teams across multiple stages of company growth, including pre-revenue, IPO, and post-IPO phases.
- Where does Wei-Li Shao work?
- Wei-Li Shao is President at Omada Health.
- Where did Wei-Li Shao go to school?
- Wei-Li Shao studied at Indiana University - Kelley School of Business (MBA, Marketing); University of Wisconsin-Madison (Bachelor Science, Biochemistry, Molecular Biology).
Same school
Also attended Indiana University - Kelley School of Business206
Scott D. DorseyInvestor at High AlphaJoe HaraVice President at Marlin Equity PartnersJack AleksanyanDirector at Marlin Equity PartnersDoug SillsPartner at Anthem Venture Management, LlcDanisha PasayaAnalyst, M&A Advisory at eGateway CapitalAaron DonenbergPortfolio Finance Associate at Energize Ventures
+ 200 more
Also attended University of Wisconsin-Madison504
Zhenyu TangInvestment Director at Intel CapitalDougAdvisor at Clear VenturesDan RuchPartner at Rho VenturesJoe HayesInvestor at LightbankGeorge RobertsInvestor at OpenView Venture PartnersBret L. BostwickMD, FAAP, FACMG, Venture Advisor at Breyer Capital
+ 498 more
Shared employers
Also worked at Omada Health22
Shahram Seyedin-NoorFounder + Managing Partner at Civilization Ventures Management, LlcTomer BerkovitzManaging Partner at aMoonNick MarkInvestor at EPIC VENTURESDr. Sachin JainPresident and CEO at Team8Olivia MattaInvestor at SUPPLY CHANGE CAPITALSachin JainObvious Champion at Obvious Ventures
+ 16 more
Also worked at Eli Lilly and Company145
David MollerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock VenturesNatalie FurneyGlobal General Counsel at Takeda VenturesRhonda PachecoPresident, U.S. Business Unit and U.S. Country Head at Takeda VenturesCarlos PayaVenture Partner at Ysios Capital
+ 139 more



.jpeg)
































